“After successful culture and identification of viable MAP in [the patient’s] blood, treatment with the MAP antibiotic regime for one year led to complete metabolic resolution of the previously avid cardiac sarcoidosis and no PET evidence of any metabolically active sarcoidosis anywhere. Such reversal of cardiac sarcoidosis has never previously been reported.”
King’s College London sponsorship forms for Crohn’s MAP Vaccine fundraising.
King’s College London sponsorship forms for use in fundraising for the Crohn’s MAP Vaccine diagnostic test.
We are very pleased to share the latest Redhill Biopharma press release .
The webcast featuring presentations from lead investigators and a Q&A will be available for 30 days on their website.
Here, the author presents current information assessing the link between numerous diseases states in humans such inflammatory bowel disease, Type 1 diabetes, rheumatoid arthritis, Hashimoto’s thyroiditis, multiple sclerosis and autism following infection with Mycobacterium avium paratuberculosis. The possibility of zoonotic transmission of the organism and its significant risk to public health safety as a consequence is also discussed.
Mary Garvey, Department of Life Science, Institute of Technology Sligo, Ash lane, Sligo, Ireland
June 2018
Read the latest updates about the vaccine trial, the KCL diagnostic test and our fundraising in our newsletter here.
https://j.ideasspread.org/index.php/mhs/article/view/72/39
June 2018